Dr. Darrell Tan (IMAGE)

St. Michael's Hospital

Dr. Darrell Tan

Caption

"Early studies of the use of this medication as post-exposure prophylaxis therapy in other coronaviruses such as SARS and MERS have been promising," said Dr. Darrell Tan, the study's lead investigator who is also a scientist at the MAP Centre for Urban Health Solutions and an infectious disease physician at St. Michael's. "These are so-called 'cousin' viruses to COVID-19 and we want to understand whether lopinavir/ritonavir as PEP could impact its spread as well."

Credit

MAP Centre for Urban Health Solutions, St. Michael's Hospital, Unity Health Toronto

Usage Restrictions

Please credit MAP Centre for Urban Health Solutions, St. Michael's Hospital, Unity Health Toronto

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.